Stanislav Glezer
Director/Board Member chez Diabetes Foundation of New Jersey
Fortune : 207 678 $ au 30/04/2024
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Kevin Smith | M | 53 | 1 ans | |
| Kevin King | M | 67 | 2 ans | |
| Thomas West | M | 60 | 1 ans | |
| Mary Ladone | F | 57 | 2 ans | |
| Glenn Boehnlein | M | 62 | 2 ans | |
| Jason Somer | M | 56 | 3 ans | |
| Gregoire Ramade | M | 54 | 1 ans | |
| Michelle Quinn | F | 56 | 5 ans | |
| Tara Charvat | F | - |
Diabetes Foundation of New Jersey
| - |
| Antoine Ezell | M | 55 | 4 ans | |
| Elizabeth McCombs | F | 48 | 5 ans | |
| Brooke Story | F | 52 | 6 ans | |
| Jennifer M. Yi Boyer | F | - | 2 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Alison Bauerlein | F | 42 | 20 ans | |
| Nabil Shabshab | M | 58 | 12 ans | |
| Vincent Forlenza | M | 70 | 41 ans | |
| Michael Sergesketter | M | 64 | 3 ans | |
| Raymond O. Huggenberger | M | 65 | 13 ans | |
| Kristin Caltrider | F | 56 | 1 ans | |
| Heath Lukatch | M | 56 | 16 ans | |
| John Gallagher | M | 51 | - | |
| George Parr | M | 53 | 6 ans | |
| Nina Elizabeth Woodard | F | - |
California Coast University
| 15 ans |
| Linda Tharby | F | 56 | - | |
| Gary A. Mecklenburg | M | 78 | 15 ans | |
| Monique N. Dolecki | F | - | 7 ans | |
| Kristen Miranda | F | 62 | 2 ans | |
| Loren McFarland | M | 65 | 9 ans | |
| Brenton Taylor | M | 42 | 21 ans | |
| David Highet | M | - | - | |
| John DeFord | M | 62 | 4 ans | |
| Benjamin M. Anderson-Ray | M | 69 | 9 ans | |
| Kristen Stewart | F | - | 2 ans | |
| Willard Overlock | M | 78 | 20 ans | |
| Lisa McCann | F | 42 | 4 ans | |
| Tobi Karchmer | M | - | 12 ans | |
| Jerry Flasz | M | - | - | |
| Duncan Fatkin | M | - | 2 ans | |
| Michael S. Simpson | M | 57 | 1 ans | |
| Neena Patil | F | 49 |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | 8 ans |
| Bart Sanford | M | 58 | 5 ans | |
| Jacob Elguicze | M | 51 | 1 ans | |
| Charles R. Bodner | M | - | - | |
| Linda J. Peters | F | - | 2 ans | |
| Kristen L. Cardillo | F | - | 6 ans | |
| Joseph Kelly | M | 55 |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | 15 ans |
| Tariq Arshad | M | 54 | 2 ans | |
| Devdatt Kurdikar | M | 56 | 1 ans | |
| Stephen Gunstream | M | 45 | 4 ans | |
| Jacqueline Scanlan | F | 51 |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | 2 ans |
| Agnes Lee | F | - | 1 ans | |
| Jesper Høiland | M | 63 |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | 30 ans |
| Edward Williams | M | 68 |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | 11 ans |
| James Borzi | M | 61 | 6 ans | |
| Steven J. Burchell | M | - |
California Coast University
| 1 ans |
| Patrick Kaltenbach | M | 60 | 3 ans | |
| Steven Williamson | M | 51 | 2 ans | |
| Brent Ashton | M | - | 2 ans |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Etats-Unis | 58 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Stanislav Glezer
- Réseau Personnel
